ReviewJournal of inflammation research2026

Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside.

Luigino Calzetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.